EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieOpen Access

Rapid Whole-Genomic Sequencing and a Targeted Neonatal Gene Panel in Infants With a Suspected Genetic Disorder

Jill L Maron, Stephen Kingsmore, Bruce D Gelb, Jerry Vockley, Kristen Wigby, Jennifer Bragg, Annemarie Stroustrup, Brenda Poindexter, Kristen Suhrie, Jae H Kim, Thomas Diacovo, Cynthia M Powell und 8 weitere

JAMA · 11.07.2023 · 330 (2) · 161

DOI: 10.1001/jama.2023.9350 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JAMA, erschienen am 11.07.2023. Verfasst von Jill L Maron und 19 weiteren Autor:innen. Beteiligte Einrichtung: Women and Infants Hospital of Rhode Island, Providence. Hauptthemen laut MEDLINE: Whole Genome Sequencing, Genetic Testing, Genetic Diseases, Inborn, Neonatal Screening. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Genomic testing in infancy guides medical decisions and can improve health outcomes. However, it is unclear whether genomic sequencing or a targeted neonatal gene-sequencing test provides comparable molecular diagnostic yields and times to return of results.

Objective

To compare outcomes of genomic sequencing with those of a targeted neonatal gene-sequencing test. Design, Setting, and Participants The Genomic Medicine for Ill Neonates and Infants (GEMINI) study was a prospective, comparative, multicenter study of 400 hospitalized infants younger than 1 year of age (proband) and their parents, when available, suspected of having a genetic disorder. The study was conducted at 6 US hospitals from June 2019 to November 2021. Exposure Enrolled participants underwent simultaneous testing with genomic sequencing and a targeted neonatal gene-sequencing test. Each laboratory performed an independent interpretation of variants guided by knowledge of the patient’s phenotype and returned results to the clinical care team. Change in clinical management, therapies offered, and redirection of care was provided to families based on genetic findings from either platform. Main Outcomes and Measures Primary end points were molecular diagnostic yield (participants with ≥1 pathogenic variant or variant of unknown significance), time to return of results, and clinical utility (changes in patient care).

Results

A molecular diagnostic variant was identified in 51% of participants (n = 204; 297 variants identified with 134 being novel). Molecular diagnostic yield of genomic sequencing was 49% (95% CI, 44%-54%) vs 27% (95% CI, 23%-32%) with the targeted gene-sequencing test. Genomic sequencing did not report 19 variants found by the targeted neonatal gene-sequencing test; the targeted gene-sequencing test did not report 164 variants identified by genomic sequencing as diagnostic. Variants unidentified by the targeted genomic-sequencing test included structural variants longer than 1 kilobase (25.1%) and genes excluded from the test (24.6%) (McNemar odds ratio, 8.6 [95% CI, 5.4-14.7]). Variant interpretation by laboratories differed by 43%. Median time to return of results was 6.1 days for genomic sequencing and 4.2 days for the targeted genomic-sequencing test; for urgent cases (n = 107) the time was 3.3 days for genomic sequencing and 4.0 days for the targeted gene-sequencing test. Changes in clinical care affected 19% of participants, and 76% of clinicians viewed genomic testing as useful or very useful in clinical decision-making, irrespective of a diagnosis. Conclusions and Relevance The molecular diagnostic yield for genomic sequencing was higher than a targeted neonatal gene-sequencing test, but the time to return of routine results was slower. Interlaboratory variant interpretation contributes to differences in molecular diagnostic yield and may have important consequences for clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Whole Genome SequencingGenetic TestingGenetic Diseases, InbornNeonatal ScreeningSequence Analysis, DNAClinical Decision-MakingGenetic ProfileGenomicsProspective StudiesHumansInfant, NewbornInfantMutation

Autor:innen und Institutionen

  • Women and Infants Hospital of Rhode Island, Providence.
  • Rady Children's Institute for Genomic Medicine, San Diego, California.
  • Mindich Child Health and Development Institute and Departments of Pediatrics and Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
  • University of Pittsburgh Medical Center Children's Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Department of Pediatrics, University of California San Diego, San Diego.
  • Division of Neonatology, Department of Pediatrics, Cohen Children's Medical Center at Northwell Health, New Hyde Park, New York, New York.

Förderung

  • NCATS NIH HHS

Zitieren

APA

Maron, J. L., Kingsmore, S., Gelb, B. D., Vockley, J., Wigby, K., Bragg, J., Stroustrup, A., Poindexter, B., Suhrie, K., Kim, J. H., Diacovo, T., Powell, C. M., Trembath, A., Guidugli, L., Ellsworth, K. A., Reed, D., Kurfiss, A., Breeze, J. L., Trinquart, L., & Davis, J. M. (2023). Rapid Whole-Genomic Sequencing and a Targeted Neonatal Gene Panel in Infants With a Suspected Genetic Disorder. JAMA, 330(2), 161. https://doi.org/10.1001/jama.2023.9350

Vancouver

Maron JL, Kingsmore S, Gelb BD, Vockley J, Wigby K, Bragg J, et al. Rapid Whole-Genomic Sequencing and a Targeted Neonatal Gene Panel in Infants With a Suspected Genetic Disorder. JAMA. 2023;330(2):161. doi:10.1001/jama.2023.9350

BibTeX
@article{Maron2023,
  author = {Maron, Jill L and Kingsmore, Stephen and Gelb, Bruce D and Vockley, Jerry and Wigby, Kristen and Bragg, Jennifer and Stroustrup, Annemarie and Poindexter, Brenda and Suhrie, Kristen and Kim, Jae H and Diacovo, Thomas and Powell, Cynthia M and Trembath, Andrea and Guidugli, Lucia and Ellsworth, Katarzyna A and Reed, Dallas and Kurfiss, Anne and Breeze, Janis L and Trinquart, Ludovic and Davis, Jonathan M},
  title = {Rapid Whole-Genomic Sequencing and a Targeted Neonatal Gene Panel in Infants With a Suspected Genetic Disorder},
  journal = {JAMA},
  year = {2023},
  volume = {330},
  number = {2},
  pages = {161},
  doi = {10.1001/jama.2023.9350}
}
Kostenlos starten →